食管鱗癌患者PER1、PER2和VEGF表達的相關(guān)性及VEGF的節(jié)律研究
[Abstract]:Aim: to investigate the relationship between the abnormal expression of Period 1 (PER1), Period 2 (PER2) and VEGF (vascular endothelial growth factor,VEGF) and clinicopathology in patients with esophageal squamous cell carcinoma. To investigate the relationship between rhythmic PER1,PER2 and rhythm related gene VEGF expression in tumor tissues. To investigate the fluctuation of VEGF in serum and urine of patients with esophageal squamous cell carcinoma and the difference of VEGF in blood between patients with esophageal squamous cell carcinoma and normal controls. Methods: (1) the expression of PER1,PER2 and VEGF mRNA in normal tissues, paracancerous atypical hyperplasia tissues and cancer groups were detected by RT-PCR. (2) the normal tissues of patients with esophageal squamous cell carcinoma were detected by Western-Blot. The expression levels of VEGF,PER1 and PER2 protein in paracancerous atypical hyperplasia and cancer tissues were collected. (3) the characteristics of cancer tissues, paracancerous tissues and normal tissues, blood samples and clinical cases were collected. The expression of PER1,PER2 and VEGF proteins in cancer tissues, paracancerous tissues and normal tissues of 144 patients with esophageal squamous cell carcinoma were detected by immunohistochemical method, and the correlation between PER,PER2 and VEGF and clinical features was observed. (4), The expression of VEGF in blood of 144 patients was detected by ELISA. (5), Blood and urine samples were collected from 9 patients with esophageal squamous cell carcinoma at four time points (0.3, 09, 15, 21) and 9 normal controls at four time points (0.3, 09, 15, 21). Elisa was used to detect 9 food. The expression of VEGF in blood and urine samples and the expression of VEGF in 9 normal subjects at four time points (03: 00, 09: 00, 15: 00, 21: 00) in patients with tubular squamous cell carcinoma understood the fluctuation of VEGF rhythm. Results: (1) the results of RT-PCR,WB showed that there were differences in the expression of VEGF,PER1 and PER2 in cancer tissues, atypical hyperplasia tissues and normal tissues, and the expression of VEGF was different in cancer tissues. The expression of PER1 and PER2 in paracancerous atypical hyperplasia tissues was higher than that in normal tissues. (2) PER1, was lower in tumor tissues and paracancerous atypical hyperplasia tissues than in normal tissues. The expression of PER2 protein in esophageal squamous cell carcinoma was negatively correlated with the clinical stage, depth of invasion, lymph node metastasis and distant metastasis, and positively correlated with the degree of differentiation. At the same time, it was also observed that the closer the tumor tissue was to the lower esophageal segment, the lower the expression of PER1,PER2 was, but not related to sex, age, educational level and tumor size. In tumor tissues, the expression of VEGF protein in blood was positively correlated with the size of tumor tissue, clinical stage, depth of invasion, lymph node metastasis and distant metastasis, but negatively correlated with the degree of differentiation. At the same time, the closer the tumor tissue was to the lower esophageal segment, the lower the expression of VEGF protein was. It is not related to sex, age and educational level. The expression of PER1,PER2 protein in tumor tissue was negatively correlated with the expression of VEGF protein in blood. (3) the expression of VEGF in urine and blood of normal human blood and esophageal squamous cell carcinoma patients fluctuated in daily rhythm. There was significant difference in the fluctuation range of VEGF between normal subjects and patients with esophageal squamous cell carcinoma at four time points a day. Conclusion: (1) the low expression of rhythm genes PER1 and PER2 and the high expression of VEGF play an important role in the occurrence and development of esophageal squamous cell carcinoma. (2) the expression of rhythm genes PER1 and PER2 affects the expression and fluctuation of VEGF.
【學位授予單位】:川北醫(yī)學院
【學位級別】:碩士
【學位授予年份】:2016
【分類號】:R735.1
【相似文獻】
相關(guān)期刊論文 前10條
1 張鵬,王雨生,張星,惠延年,胡丹,馬吉獻;缺氧對人視網(wǎng)膜色素上皮細胞增生和VEGF表達的影響[J];眼科新進展;2004年01期
2 黃欣,溫玉明,李龍江;外周血VEGF表達水平與舌癌頸淋巴結(jié)轉(zhuǎn)移關(guān)系的臨床研究[J];實用口腔醫(yī)學雜志;2004年03期
3 于曉紅;楊穎;周亞濱;;益心定悸方含藥血清對人臍靜脈內(nèi)皮細胞VEGF表達影響的研究[J];天津中醫(yī)藥大學學報;2013年02期
4 郭惠蘭,謝華,謝東北,劉錫儀,黃紹軒;兔骨髓間充質(zhì)干細胞分化成骨及VEGF表達[J];解剖學研究;2003年04期
5 鐘麗紅;魏春敏;李魯楊;;益腦顆粒對衰老慢性腦缺血大鼠腦組織中VEGF表達的影響[J];中國老年學雜志;2009年10期
6 劉利利;;3日齡大鼠缺氧缺血性腦損傷腦組織VEGF表達變化探討[J];中國醫(yī)學創(chuàng)新;2012年20期
7 趙煒,王雨生,張瑞,張鵬,惠延年;p42/p44 MAPK信號轉(zhuǎn)導通路在缺氧誘導的人視網(wǎng)膜色素上皮細胞VEGF表達中的作用[J];眼科新進展;2005年02期
8 蘭蘭;王雨生;王耀春;張鵬;;磷脂酰肌醇-3激酶信號通路在缺氧誘導的人視網(wǎng)膜色素上皮細胞VEGF表達中的作用[J];國際眼科雜志;2006年03期
9 程琦;宋文剛;王寧;張延新;張印坡;;類風濕性關(guān)節(jié)炎滑膜組織中VEGF表達及臨床意義[J];中國當代醫(yī)藥;2011年25期
10 吳云剛,童培建,肖魯偉,馬鎮(zhèn)川;激素性股骨頭壞死介入治療過程中VEGF表達的實驗研究[J];中國中醫(yī)骨傷科雜志;2002年04期
相關(guān)會議論文 前10條
1 勵建安;黃澎;袁紅潔;;有氧訓練對慢性冠狀動脈狹窄豬心肌VEGF表達的影響[A];2002年第9屆全國運動醫(yī)學學術(shù)會議論文摘要匯編[C];2002年
2 葉群如;彭清華;張波濤;;蠐螬對實驗性視網(wǎng)膜靜脈阻塞兔VEGF表達的影響及意義[A];中華中醫(yī)藥學會第七次眼科學術(shù)交流會論文匯編[C];2008年
3 蔣紅芝;黃光英;張明敏;;針刺對局部腦缺血大鼠VEGF表達和腦血流的影響[A];全國血栓/止血與微循環(huán)學術(shù)會議論文匯編[C];2006年
4 陸化;胡慧瑾;李俊霞;費小明;李建勇;;硼替佐米對骨髓間充質(zhì)干細胞VEGF表達影響的研究[A];第13屆全國實驗血液學會議論文摘要[C];2011年
5 嚴瑞蘭;辛曉燕;王健;王德堂;錢新華;金明;惠宏襄;;抗VEGF發(fā)卡狀核酶基因抑制VEGF表達及卵巢癌細胞增殖的實驗研究[A];中國抗癌協(xié)會婦科腫瘤專業(yè)委員會第六次全國學術(shù)會議論文匯編[C];2001年
6 孫善珍;張曉英;宋纓;王霞;楊美香;曲迅;;缺氧對人Tca8113細胞HIF-1α、VEGF表達水平的影響[A];中華口腔醫(yī)學會第七屆全國口腔病理學術(shù)會議論文摘要匯編[C];2006年
7 連方;劉海萍;王云霞;張建偉;孫振高;馬鳳梅;張寧;劉延荷;孟茜;;子宮內(nèi)膜異位癥在位內(nèi)膜VEGF和Ki-67的表達及祛瘀解毒方對在位內(nèi)膜VEGF表達的影響[A];全國中醫(yī)婦科第六次學術(shù)研討會論文匯編[C];2006年
8 李飛;李樹清;;不同腦溫對樹,
本文編號:2475121
本文鏈接:http://sikaile.net/yixuelunwen/zlx/2475121.html